80 subscribers
התחל במצב לא מקוון עם האפליקציה Player FM !
פודקאסטים ששווה להאזין
בחסות
How Can AI Help Predict Patient Drug Response? (Genialis)
Manage episode 373752301 series 2359900
Drug development is undeniably expensive. For years, the pharmaceutical industry cited an estimate of 3 billion US dollars. However, a recent study published in 2020 discovered that the median cost actually falls between 985 million and 1.3 billion US dollars. Even within this range, it remains a substantial amount. The high cost primarily stems from the significant failure rate of new potential medications that never progress beyond clinical trials. Computational biology and AI have already assumed significant roles in drug development. The aspiration is for them to expedite the creation of new, more precise, and tailored medications. Today, we will delve into biotech and explore how technology aids in predicting a specific patient's response to a particular drug. In a conversation with Rafael Rosengarten, the CEO of Genialis - a company using machine learning and high-throughput omics data to capture underlying disease biology and predict how patients will likely respond to targeted therapies, we explored the impact of computational biology on drug development and pricing, the application of generative AI in discovering novel molecules, and the challenges companies encounter in acquiring patient data to advance their work.
Sponsor: Magic Mind
Learn more at: magicmind.com/digitalhealth
Use the code: digitalhealth20
Find more at:
www.facesofdigitalhealth.com
Newsletter: https://fodh.substack.com/
352 פרקים
Manage episode 373752301 series 2359900
Drug development is undeniably expensive. For years, the pharmaceutical industry cited an estimate of 3 billion US dollars. However, a recent study published in 2020 discovered that the median cost actually falls between 985 million and 1.3 billion US dollars. Even within this range, it remains a substantial amount. The high cost primarily stems from the significant failure rate of new potential medications that never progress beyond clinical trials. Computational biology and AI have already assumed significant roles in drug development. The aspiration is for them to expedite the creation of new, more precise, and tailored medications. Today, we will delve into biotech and explore how technology aids in predicting a specific patient's response to a particular drug. In a conversation with Rafael Rosengarten, the CEO of Genialis - a company using machine learning and high-throughput omics data to capture underlying disease biology and predict how patients will likely respond to targeted therapies, we explored the impact of computational biology on drug development and pricing, the application of generative AI in discovering novel molecules, and the challenges companies encounter in acquiring patient data to advance their work.
Sponsor: Magic Mind
Learn more at: magicmind.com/digitalhealth
Use the code: digitalhealth20
Find more at:
www.facesofdigitalhealth.com
Newsletter: https://fodh.substack.com/
352 פרקים
כל הפרקים
×
1 Longevity and health span: Do you want to live forever or live well? 57:00

1 How do we redefine medical evidence in the age of AI? 44:19

1 Opening the Vault: Germany’s Health Data Soon Accessible for Research 37:38

1 How is Europe preparing for secondary use of data in healthcare through EHDS? 44:00

1 How is Europe preparing for secondary use of data in healthcare through EHDS? 44:00

1 Why are clinicians leaving medical practice? 34:45

1 Why Patients Lie—and How AI is Helping Doctors See the Truth 22:39

1 Agentic AI and Longevity - Key topics at NextMed Health 2025 43:35

1 NHS England Abolished: Lessons from Past Restructurings and Future Impact 41:36

1 How does Cleveland Clinic London invest in AI and healthcare IT? 22:03

1 HIMSS Global 2025: AI is everywhere 18:52

1 NextMed Health 2025: Agentic AI in healthcare and beyond 15:42

1 Decoding Cancer: AI, Biomarkers & Precision Medicine 41:38

1 How to Identify High-Quality Digital Health Apps: The DIME Seal Explained 35:33

1 OneLondon: Building a Connected Health Ecosystem for 10 Million People 30:37

1 How Is NHS Working With Innovation and Startups? (Mindy Simon) 25:10

1 "The hardest technology is behaviour change" - Daniel Kraft 33:18

1 What does NVIDIA do in healthcare? 39:36

1 Portugal: Centralizing Digital Health Decision Making and Solution Design 53:17

1 Optimizing Healthcare IT in Canadian Hospitals: Data Standards, Governance, and Digital Literacy 41:50

1 What Does Good Healthcare Consulting Look Like? 1:00:03

1 Digital Health Strategy in Spain and Catalonia (Jordi Piera Jiménez) 51:00

1 Artur Olesch on the use of health data, European policy and book recommendations 43:52

1 It's time for AI credibility scores (John Halamka, President of Mayo Clinic Platform) 14:53

1 Would you Pay $2500 for a Preventative MRI Scan? 21:33

1 HLTH Europe 2024: AI, Patients, Women's health, and more 24:51

1 Women's Health: What it is, how it's funded and what changes do we need? (Joy Rios) 28:19

1 HIMSS Europe 2024: EHDS, future of interoperability, next steps in AI, and where patient journey fits in? 33:16

1 Can We Harmonize Medication Management Across Europe? 36:52

1 Learning From pan-Canadian Health Data Strategy - What's Next to EHDS? (Eric Sutherland) 43:21

1 How is Italy digitalizing healthcare in its 20 regions? 33:38

1 How does an acquisition look like from a startup founder and investor perspective? 36:21

1 Holiday Edition: Future Trends in Digital Health & AI (Daniel Kraft, Lucien Engelen, Zayna Khayat) 44:24

1 How can healthcare companies improve their marketing? (Dr James Somauroo) 45:10

1 How will health AI assurance labs look like and who will pay for assessments? 30:15

1 How Can Hospitals Advance Their Digital Transformation With HIMSS Maturity Models? 1:00:31

1 How does remote patient monitoring look like in South Africa and Nigeria? 36:02

1 How can startups avoid failure? Listen better. (Laura Hilty) 17:12

1 The future of data in in collaboration among standards bodies (Rachel Dunscombe) 10:04

1 Zayna Khayat: Language, Mindset and the Future of Care 30:07

1 How Patients Use AI (Grace Vinton, Grace Cordovano) 19:08

1 Gary Monk on DTx and Common Sense in Analysing Wellness Data From Apps and Wearables 17:16

1 How Successful Digital Intervention Can Be in Mental Health? 20:35

1 What is Impact Investing and Why You Should Consider Patenting Your Ideas (Michael Friebe) 40:12

1 Where is Healthcare IT in Europe in 2024? (Tomaz Gornik) 49:09
ברוכים הבאים אל Player FM!
Player FM סורק את האינטרנט עבור פודקאסטים באיכות גבוהה בשבילכם כדי שתהנו מהם כרגע. זה יישום הפודקאסט הטוב ביותר והוא עובד על אנדרואיד, iPhone ואינטרנט. הירשמו לסנכרון מנויים במכשירים שונים.